193 related articles for article (PubMed ID: 31526409)
1. Periodontal disease and effects of antipsychotic medications in patients newly diagnosed with schizophrenia: a population-based retrospective cohort.
Hu KF; Ho PS; Chou YH; Tsai JH; Lin CR; Chuang HY
Epidemiol Psychiatr Sci; 2019 Sep; 29():e49. PubMed ID: 31526409
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic medications and dental caries in newly diagnosed schizophrenia: A nationwide cohort study.
Hu KF; Chou YH; Wen YH; Hsieh KP; Tsai JH; Yang P; Yang YH; Lin CR
Psychiatry Res; 2016 Nov; 245():45-50. PubMed ID: 27526316
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients.
Nielsen J; Skadhede S; Correll CU
Neuropsychopharmacology; 2010 Aug; 35(9):1997-2004. PubMed ID: 20520598
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study.
Chen VC; Liao YT; Lai TJ; Lane HY; Shao WC; Dewey M; Lee CT; Lu ML
Schizophr Res; 2015 Dec; 169(1-3):406-411. PubMed ID: 26481616
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.
Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H
Schizophr Bull; 2022 Jan; 48(1):166-175. PubMed ID: 34286338
[TBL] [Abstract][Full Text] [Related]
6. Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: a nested case-control study.
Hsieh PH; Hsiao FY; Gau SS; Gau CS
J Clin Psychopharmacol; 2013 Jun; 33(3):299-305. PubMed ID: 23609396
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of dementia in patients with Schizophrenia: A population-based cohort study in Taiwan.
Lin CE; Chung CH; Chen LF; Chi MJ
Eur Psychiatry; 2018 Sep; 53():7-16. PubMed ID: 29859379
[TBL] [Abstract][Full Text] [Related]
8. Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.
Rajkumar AP; Horsdal HT; Wimberley T; Cohen D; Mors O; Børglum AD; Gasse C
Am J Psychiatry; 2017 Jul; 174(7):686-694. PubMed ID: 28103712
[TBL] [Abstract][Full Text] [Related]
9. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
10. Associations among antipsychotics, metabolism-related diseases, and cataracts in patients with schizophrenia: A retrospective cohort study.
Fang SC; Huang CY; Liao DL; Hsu CC; Shao YJ
Schizophr Res; 2019 Oct; 212():150-156. PubMed ID: 31395489
[TBL] [Abstract][Full Text] [Related]
11. Association between antipsychotic use and risk of acute myocardial infarction: a nationwide case-crossover study.
Lin ST; Chen CC; Tsang HY; Lee CS; Yang P; Cheng KD; Li DJ; Wang CJ; Hsieh YC; Yang WC
Circulation; 2014 Jul; 130(3):235-43. PubMed ID: 24838361
[TBL] [Abstract][Full Text] [Related]
12. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.
Tiihonen J; Haukka J; Taylor M; Haddad PM; Patel MX; Korhonen P
Am J Psychiatry; 2011 Jun; 168(6):603-9. PubMed ID: 21362741
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.
Bloechliger M; Rüegg S; Jick SS; Meier CR; Bodmer M
CNS Drugs; 2015 Jul; 29(7):591-603. PubMed ID: 26242478
[TBL] [Abstract][Full Text] [Related]
14. The effect of antipsychotic medication and the associated hyperprolactinemia as a risk factor for periodontal diseases in schizophrenic patients: a cohort retrospective study.
Shalaby R; Elmahdy A; Mikhail C
BMC Oral Health; 2023 Oct; 23(1):786. PubMed ID: 37875841
[TBL] [Abstract][Full Text] [Related]
15. Adherence patterns with first- versus second-generation antipsychotics for newly diagnosed schizophrenia in Taiwan.
Chang CM; Wu KY; Liang HY; Wu EC; Chen CY; Wu CS; Chen SJ; Chang TK; Tsai HJ
Psychiatr Serv; 2012; 63(5):504-7. PubMed ID: 22549537
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk among gingivitis and periodontitis patients: a nationwide cohort study.
Wen BW; Tsai CS; Lin CL; Chang YJ; Lee CF; Hsu CH; Kao CH
QJM; 2014 Apr; 107(4):283-90. PubMed ID: 24336850
[TBL] [Abstract][Full Text] [Related]
17. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
[TBL] [Abstract][Full Text] [Related]
18. Weight gain on antipsychotic medication is associated with sustained use among veterans with schizophrenia.
Monnelly EP; Fonda J; Gagnon DR; Chittamooru S; Lawler EV
J Clin Psychopharmacol; 2015 Feb; 35(1):57-62. PubMed ID: 25514067
[TBL] [Abstract][Full Text] [Related]
19. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
[TBL] [Abstract][Full Text] [Related]
20. Association of antipsychotics adherence and cardiovascular disease among newly diagnosed schizophrenia patients: A national cohort among Koreans.
Chang J; Kim JA; Kim K; Choi S; Kim SM; Nam YY; Park S; Goo AJ; Park SM
Asian J Psychiatr; 2020 Aug; 52():102161. PubMed ID: 32454424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
